Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiogenesis in tissue-engineered small intestine.

James Gardner-Thorpe1, Tracy C Grikscheit, Hiromichi Ito

  • 1Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

Tissue Engineering
|December 13, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical Safety after Preoperative Chemotherapy for Perihilar Cholangiocarcinoma: Multi-Institutional Propensity-Matched Analysis.

Annals of surgical oncology·2026
Same author

Feasibility of Surgical Resection for Advanced Gallbladder Carcinoma Based on Preoperative Clinical T Stagings: A Multicenter Retrospective Analysis (SNOW-22-05).

Journal of hepato-biliary-pancreatic sciences·2026
Same author

Dracunculus sp. PantanalBr Infection in Florida Panthers and Bobcat, Florida, USA.

Emerging infectious diseases·2026
Same author

Clinical Impact of Early Positive Drain Culture on Outcomes and Management After Pancreaticoduodenectomy.

Journal of hepato-biliary-pancreatic sciences·2026
Same author

High Incidence of Anastomotic Stenosis in Pancreatoduodenectomy with Distal Portal Vein Resection: An Ileocolic Vein-Based Anatomical Definition.

Journal of the American College of Surgeons·2026
Same author

Retraction Note: GPT-4 as a Board-Certified Surgeon: A Pilot Study.

Medical science educator·2026

Tissue-engineered intestine shows potential for short bowel syndrome. Angiogenesis in engineered tissue differs from native bowel, suggesting growth factor delivery could improve bioengineering.

Area of Science:

  • Regenerative Medicine
  • Vascular Biology
  • Gastroenterology

Background:

  • Tissue-engineered intestine is a promising therapy for short bowel syndrome.
  • Understanding the microvasculature and growth factor profiles is crucial for optimizing engineered tissues.

Purpose of the Study:

  • To characterize the microvasculature and angiogenic growth factor profile of tissue-engineered intestine over time.
  • To compare these characteristics with native juvenile rat bowel.

Main Methods:

  • Tissue-engineered small intestinal grafts were harvested from Lewis rats 1-8 weeks post-implantation.
  • Architectural similarity was assessed using H&E staining.
  • Capillary density was measured via CD34 immunohistochemistry.
  • Vascular Endothelial Growth Factor (VEGF) and basic Fibroblast Growth Factor (bFGF) levels were quantified using ELISA.

Related Experiment Videos

Main Results:

  • Engineered cysts increased significantly in volume and mass over 8 weeks.
  • Muscular and mucosal layers thickened, but capillary density remained constant.
  • Engineered intestine had significantly lower VEGF and bFGF levels compared to native juvenile rat bowel.

Conclusions:

  • The mechanisms driving angiogenesis in engineered intestine differ from those in native bowel.
  • Supplementation with VEGF and bFGF may be beneficial for improving the vascularization of bioengineered intestine.